Evotec and Novo Nordisk enter into technology development …
网页3 天之前 · Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies. Hamburg, Germany, 26 September 2024:
Evotec and Novo Nordisk Enter into Technology Development
网页3 天之前 · Evotec SE announced today that Evotec has entered a technology development partnership with Novo Nordisk in cell therapy. Under the collaboration agreement, Novo Nordisk will provide...
Evotec and Novo Nordisk in technology development partnership
网页3 天之前 · German drug and development company Evotec has entered into a technology development partnership with Novo Nordisk to support clinical and commercial manufacturing of stem cell-based...
Evotec and Novo Nordisk Enter into Technology Development …
网页3 天之前 · Novo Nordisk will provide funding for technology development activities at Evotec to support clinical and commercial manufacturing of stem cell-based therapies
Novo, Evotec Ink Stem Cell Partnership as Drugmaker Looks to …
网页2 天之前 · Novo Nordisk and German biotech Evotec announced Thursday that they have entered into a technology development agreement to advance off-the-shelf, stem cell-based therapies. Details of the deal were scant.
Evotec and Novo Nordisk form strategic alliance to develop novel ...
网页2020年8月18日 · Evotec and Novo Nordisk will jointly identify and develop novel targets based on comprehensive medical and molecular data sets of thousands of chronic kidney disease patients. The collaboration intends to pursue the most relevant human disease biology in a therapeutic modality-agnostic approach to develop first-in …
Evotec and Novo Nordisk launch LAB eN² to accelerate translation …
网页2023年9月26日 · LAB eN² was created to provide a solution-focused pathway for academic researchers, with a mission to accelerate the translation of their academic discoveries into investigational new drug (“IND”) candidates for cardiometabolic diseases as well as rare blood and rare endocrine disorders.
Novo Nordisk and Evotec collaborate to launch LAB eN², a …
网页2023年9月26日 · LAB eN² is a unique engagement model that combines Evotec's multimodality drug discovery and preclinical development capabilities with Novo Nordisk's therapeutic, clinical, and commercial...
News details - Novo Nordisk
网页2023年9月26日 · Novo Nordisk and Evotec collaborate to launch LAB eN², a translational drug discovery accelerator, to address innovation gap in cardiometabolic diseases. LAB eN ² will involve institutions including Harvard University, Mass General Brigham, and Beth Israel Deaconess Medical Center.
Evotek to Partner With Ozempic Maker Novo Nordisk on Stem
网页3 天之前 · The German biotech said Thursday that the Danish drug company, which makes weight-loss drugs Ozempic and Wegovy, will fund Evotec's research and development efforts through an undisclosed upfront...